Business
BATM Launches Antibody Tests for COVID-19
BATM Launches Antibody Tests for COVID-19.
About this update from Batm Advanced Communications Ltd.
[{"type":"text","content":"\n \n \n RNS Number : 8843L\n BATM Advanced Communications Ld\n 05 May 2020\n \n \n \n \n LEI: \n 213800FLQUB9J289RU66\n \n \n 5 May 2020\n \n \n \n \n \n BATM Advanced Communications Limited\n \n \n (\"BATM\" or \"the Group\")\n \n \n \n \n \n BATM launches Antibody Tests for COVID-19 and Commences Sale to European Countries \n \n \n Shipping commenced to several customers in Europe and ramp up occurring to fulfil further orders\n \n \n \n \n \n BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that its Adaltis subsidiary has launched ELISA Serological Test Kits that diagnose if a patient has had COVID-19 by detecting antibodies against it present in their blood. \n \n \n \n \n \n The Adaltis Serological Tests are fully CE certified and the Group has commenced shipping initial orders to several customers in Europe. It is now ramping up production for larger quantities to fulfil further orders received from these customers.\n \n \n \n \n \n Antibodies are proteins produced by the body in response to harmful substances called antigens (e.g. a virus). ELISA (enzyme-linked immunosorbent assay) serological tests measure the amount of various antibodies present in the blood when the body is responding to a specific infection, like COVID-19. The ELISA serological test detects the body's immune response to the infection caused by the virus rather than detecting the virus itself - to help identify those who have been infected and developed antibodies that may protect them from future infection. \n \n \n \n \n \n Adaltis' ELISA Serological Tests for COVID-19 are designed to test for IgA and IgM (antibodies produced within approximately 4-5 days of the immune system response) as well as IgG antibodies (which are produced after a few weeks and stay present in the body for at least several months), which the Group believes enables the detection of COVID-19 antibodies at an earlier stage than with many competing tests. In addition, Adaltis' tests can be conducted both on standard ELISA machines that are already in widespread use in laboratories and hospitals, and on Adaltis' Personal LAB and NEXgen machines, which are pre-calibrated for these tests. Details of these instruments can be found on the Adaltis ...